Hypertension treatment with angiotensin-converting enzyme inhibitors could have prevented muscle loss in our study participants and may have interfered with the rates of sarcopenia, as these agents prevent declines in skeletal muscle mass and strength independent of their hemodynamic effects [37]. The gene discussed is ACE; the disease is hypertensive disorder.